Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Frontiers in Neuroendocrinology
|
October 6, 2001
Neuroendocrine tumor markers
S W Lamberts, L J Hofland, F R Nobels
European Journal of Clinical Investigation
|
August 7, 1998
Chromogranin A: its clinical value as marker of neuroendocrine tumours
F R Nobels, D J Kwekkeboom, R Bouillon, et al.
Diabete & Metabolisme
|
May 1, 1988
Hypertension in obese and non-obese non-insulin dependent diabetics a matter of regional adiposity?
L F Van Gaal, F R Nobels, E G Rillaerts, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1993
A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas
F R Nobels, D J Kwekkeboom, W Coopmans, et al.
European Journal of Endocrinology
|
December 1, 1994
Serum chromogranin A in the differential diagnosis of Cushing's syndrome
F R Nobels, W W de Herder, D J Kwekkeboom, et al.
Acta Endocrinologica
|
July 1, 1993
Current tools in the diagnosis of pituitary tumours
S W Lamberts, W W de Herder, D J Kwekkeboom, et al.
Clinical Endocrinology
|
December 1, 1996
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand
W W de Herder, A E Reijs, D J Kwekkeboom, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1997
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones
F R Nobels, D J Kwekkeboom, W Coopmans, et al.
European Journal of Endocrinology
|
November 18, 2000
Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma
F R Nobels, W W de Herder, W M van den Brink, et al.
The American Journal of Medicine
|
April 1, 1994
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion
W W de Herder, E P Krenning, C D Malchoff, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Frontiers in Neuroendocrinology
|
October 6, 2001
Neuroendocrine tumor markers
S W Lamberts, L J Hofland, F R Nobels
European Journal of Clinical Investigation
|
August 7, 1998
Chromogranin A: its clinical value as marker of neuroendocrine tumours
F R Nobels, D J Kwekkeboom, R Bouillon, et al.
Diabete & Metabolisme
|
May 1, 1988
Hypertension in obese and non-obese non-insulin dependent diabetics a matter of regional adiposity?
L F Van Gaal, F R Nobels, E G Rillaerts, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1993
A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas
F R Nobels, D J Kwekkeboom, W Coopmans, et al.
European Journal of Endocrinology
|
December 1, 1994
Serum chromogranin A in the differential diagnosis of Cushing's syndrome
F R Nobels, W W de Herder, D J Kwekkeboom, et al.
Acta Endocrinologica
|
July 1, 1993
Current tools in the diagnosis of pituitary tumours
S W Lamberts, W W de Herder, D J Kwekkeboom, et al.
Clinical Endocrinology
|
December 1, 1996
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand
W W de Herder, A E Reijs, D J Kwekkeboom, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1997
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones
F R Nobels, D J Kwekkeboom, W Coopmans, et al.
European Journal of Endocrinology
|
November 18, 2000
Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma
F R Nobels, W W de Herder, W M van den Brink, et al.
The American Journal of Medicine
|
April 1, 1994
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion
W W de Herder, E P Krenning, C D Malchoff, et al.
Page
of 1